Scale bar = 10 µm. (C) Quantitation of mCherry-Syt4 vesicle velocity and mobile vesicle % in control and nocodazole treated conditions, indicating that vesicle mobility is microtubule dependent (n= 4950 vesicles/13 videos and 4766 vesicles/13 videos for control and nocodazole-treated conditions, respectively, from 3 di erent cultures each; signi cance was determined by Student's t-test with Bonferroni correction; error = s.e.m.; * p < 0.05 and *** p < 0.001).
mCherry-syt4
mCherry-syt4 S135A mCherry-syt4 S135E (A) Images of dendritic regions marked with EGFP (top panels) in neurons co-transfected with mCherry-Syt4, mCherry-Syt4 S135A, or mCherry-Syt4 S135E and imaged for 5 min. for vesicle tra cking indicated by color-coded mobile vesicle tracks (middle panels) and in kymographs (bottom panels).
(B) Quantitation of average velocity, and mobile vesicle percentage (C) of control, S135A and S135E Syt4-harboring vesicles in dendrites, normalized to wild-type axons (100%), for comparison (n = 1319, 1489 and 1088 vesicles for average speed and velocity, and n = 13, 13 and 14 videos for mobile percentage of control, S135A and S135E vesicles, respectively, from 4 di erent cultures). Scale bars = 5 µm in all panels. Signi cance was determined by Student's t-test with Bonferroni correction; error indicates s.e.m.; * p < 0.05, ** p < 0.01 and *** p < 0.001 . B   26  52  78  104  130  156  182  208  234  260  286  312  338  364  390 Figure S3 . Domain organization of Syt4 and S135 phosphorylation-dependent interaction with Kif1A . Related to Figure 3. (A) The 425 amino acid Syt4 protein is anchored in the membrane by a helical transmembrane region (alpha, red), followed by a 114 residue linker and two C2 domains (C2A, C2B), which contain buried (B, orange) beta-sandwich structure (beta, blue). The linker between the transmembrane and C2 domains is predicted to be exposed (E, blue) and corresponds to an intrinsically disordered region (IDR, green). Potential protein-protein interaction (PPI) sites are marked. (B) Residue-speci c disorder propensity scores of Syt4 calculated by PONDR-FIT (VLXT, VL3, VSL2) and IUPred. (C) Secondary structure propensities of Syt4 residues E130-L154 according to s2d (Sormanni et al., 2015) . Helical propensities are shown in blue. Residues E130-L154 have a propensity for poly-proline II structure; S135-K140 and L145-K153 have a propensity for alpha-helical structure. Cropped dendritic regions of hippocampal neurons co-transfected with PSD95-GFP and mCherry-tagged Syt4, Syt4 S135A or Syt4 S135E. (C) Quanti cation of percent of Syt4 colocalizing with PSD95-GFP, showing no di erence in co-localization of PSD95-GFP with mCherry-Syt4, mCherry-Syt4 S135A or mCherry-Syt4 S135E (n= 23, 19 and 20 cells for PSD95-GFP co-transfected with mCherry-Syt4, mCherry-Syt4 S135A and mCherry-Syt4 S135E, respectively from 3 di erent cultures). Scale bar = 5 µm. Signicance was determined by Student's t-test with Bonferroni correction; error indicates s.e.m.; * p < 0.05, ** p < 0.01 and *** p < 0.001. When Syt4 is in the non-phosphorylated compact form (middle panel), two Syt4 molecules bind to a Kif1A dimer in a 1:1 ratio via their C2 domains to clamp and stabilize Kif1A dimers in a processive conformation (middle panel). This C2-C2 interaction would also disrupt potential interaction of Kif1A DEP-PH domains, allowing the PH domain (and C2 domains of Syt4 and Kif1A) to bind vesicle membranes to stabilize the complex. The S135 site is surface accessible in this conformation. When Syt4 is phosphorylated, the linker region changes conformation such that the compact structure of Syt4 is destabilized, resulting in a loosening of the "clamp" between C2 domains, decreased interaction of C2 and PH domains with vesicle membranes, and release of vesicles (right panel).
Supplemental Experimental Procedures
Hippocampal neuron culture Hippocampal neurons were isolated from E18-19 Wistar rats as previously described (Banker and Cowan, 1977) . Extracted hippocampi were dissociated by treatment with 0.05 mg/ml trypsin for 20 min followed by trituration and filtering through a 100 µm cell strainer (BD Biosciences). Cells were plated in Neurobasal medium supplemented with B27, GlutaMAX and 100 U/ml penicillin/streptomycin (Gibco) on 12 mm glass coverslips (Carolina Biologicals) coated with 0.04% polyethyleneimine (PEI, Sigma) or 0.5 mg/ml poly-D-lysine (PDL, Sigma) in 24-well plates at a density of 80,000 cells/ well. Cultures were maintained at 37°C in a 5% CO 2 humidified incubator.
Hippocampi from Syt4 knockout mice (Jackson Laboratory; (Ferguson et al., 2000) ) were removed from P0 mouse brains in cold dissection medium (Gibco HBSS, 20 mM HEPES, 1.5 mM CaCl 2 , 10 mM MgCl 2 , pH adjusted to 7.4 with NaOH) and incubated in papain solution (dissection medium, L-Cysteine, NaEDTA, CaCl 2 , NaOH, Papain equilibriated in 37° C and 5% CO 2 + DNAseI) for 30 min at 37 °C and 5% CO 2. Papain was inactivated with 5% serum medium (DMEM+glutamax, 5% BSA, Mito+ serum extender, MEM vitamins, DNAseI). Cells were triturated and then centrifuged for 5 min at 500 g at room temp. The cell pellet was resuspended in plating medium (Neurobasal, penicillin/streptomycin, B27, L-Asp acid, L-Glu acid, glutamax, 0.5% serum medium). Cells were plated at 120,000 cells/ well on 12 mm diameter acid-etched 0.04% PEI-coated glass coverslips. FUDR was added on DIV4 to block glial proliferation. 50% conditioned medium was replaced with feeding medium (Gibco Neurobasal, Glutamax, Pen/Strep, B27) on DIV7.
Mammalian expression constructs, antibodies and reagents
AAV-ESYN-mCherry-Syt4, AAV-ESYN-mCherry-Syt4(S135A) and AAV-ESYN-mCherrySyt4(S135E) were constructed by sub-cloning WT or mutagenized rat Syt4 fused to an Nterminal mCherry into an AAV plasmid backbone with an enhanced synapsin promoter. CgA-GFP, Synaptophysin-GFP, PSD95-GFP, Bassoon-GFP, and LifeAct-RFP were provided by Thomas Dresbach (University Medical School, Goettingen, Germany), NPY-mCherry was provided by Matthijs Verhage (Vrije Universitt Amsterdam). AAV-ESYN-mCherry-Syt4-P2A-FlagJNK1a1(APF) (called JNK1(APF)), AAV-ESYN-mCherry-Syt4-P2A-FlagMKK7B2JNK1a1 (called MKK7-JNK1) and AAV-ESYN-mCherry-Syt4(S135A)-P2A-FlagMKK7B2JNK1a1 (called S135A/MKK7-JNK1) were made by GenScript Biotech Corporation (Piscataway, NJ, USA), by inserting a P2A site and FlagJNK1a1(APF) (Addgene # 13846) or FlagMKK7B2JNK1a1 (Addgene # 19726) provided by Roger Davis (Howard Hughes Medical Institute, University of Massachusetts Medical School, USA), downstream of Syt4 in AAV-ESYN-mCherry-Syt4 or AAV-ESYN-mCherry-Syt4(S135A). N-terminal His-tagged WT, S135A and S135E plasmids in pET28a were synthesized by Genscript Biotech Corporation (Piscataway, NJ, USA). GST-Kif1A was provided by Geri Kreitzer (City University of New York, USA), Kif1A-GFP, and Kif1A knockdown and rescue constructs (Lo et al., 2011) 
Lipofectamine transfection
Neurons were transfected at DIV3 or DIV10 using Lipofectamine 2000 (Invitrogen), according to the manufacturer's protocol. For each well of a 24-well plate, 1 µl Lipofectamine 2000 was added to 50 µl Neurobasal medium in one tube, and 0.75 µg DNA was added to 50 µl Neurobasal medium in another tube, and incubated separately for 5 min The contents of these tubes were then mixed and incubated for 20 min at room temperature. Conditioned medium was removed from wells, saved, and replaced with 400 µl fresh Neurobasal medium without supplements. The Lipofectamine/DNA mixture was then added to wells, incubated for two hours at 37 °C and 5% CO 2 , and then removed, washed once with Neurobasal medium and replaced with saved conditioned media. For co-transfections, 0.75 µg of DNA total was added per well (i.e. 0.375 µg of each construct).
Live cell imaging
For trafficking experiments, cells were imaged at room temperature on DIV13-15, with the exception of overexpressed active or dominant-negative JNK which were imaged on DIV11. Transfected coverslips were transferred to a live imaging chamber (Warner Instruments) containing 150 µl of Tyrode's solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 5.5 mM glucose, 20 mM Hepes, pH=7.3). Healthy neurons were selected by morphology for live imaging in 90 µm x 90 µm fields of view in which intact processes were visible and in which at least a few vesicles were moving. Images were acquired with 450-490ex/505-555em filters for GFP and 545-570ex/575-680em filters for mCherry on a Zeiss AxioObserver inverted microscope with a Photometrics Evolve EMCCD camera, and Lambda DG-4 high-speed wavelength switcher at 1 s intervals using Metamorph software (Molecular Devices). For pharmacological experiments, cells were treated with 10 µM nocodazole, 10 µM latrunculin, or 1 µM jasplakinolide for 30 min prior to imaging, or 10 µM SP600125 or 50 µg/ml anisomycin for 2-4 h before imaging. For activity-dependent pause experiments, high KCl solution (100 mM NaCl, 90 mM KCl, 10 mM CaCl 2 , 2 mM MgCl 2 , 5.5 mM glucose, 20 mM Hepes, pH=7.3) was applied by pipette for 3 minutes during time-lapse recording followed by perfusion with base Tyrode's solution.
Following acquisition, vesicles in imaged regions containing multiple contiguous processes 10-100 µm in length, were identified and their mobility analyzed using the particletracking module of Imaris 7.6.4 (Bitplane). For quantitation of vesicle movement and pausing, positional data from Imaris were imported into Matlab and analyzed with custom-written Matlab programs (Mathworks, Natick, MA, USA). Vesicles present for less than 3 s in the field of view were not included in analysis. Track velocity and mobile vesicle percentage (percentage of vesicles with a track duration of at least 10 s and velocity of at least 1 µm) were calculated. Pauses were defined as a drop in vesicle velocity below 0.1 µm/s (Bury and Sabo, 2011). Vesicles that were moving or paused for the entire duration of a time-lapse were excluded from average pause time analysis. Because vesicle parameters exhibited the highest variance and standard deviation (compared to neuronal processes, videos, coverslips, or cultures), vesicles were used for n number of all trafficking parameters except mobile percentage (for which video number was used). We did not consider cells as n number because fields of view often included multiple transfected axons from different cells. Kymographs were generated and analyzed using Metamorph software. For analysis of activity-dependent pauses, only mobile vesicles visible for the entire duration of high KCl stimulation were considered. Vesicles in kymographs were defined as pausing if they were immobilized during stimulation for at least 120 seconds (two thirds of the total time of stimulation). Statistical significance was determined by Student's t test, with Bonferroni Correction for multiple comparisons.
Immunocytochemistry and fixed cell imaging and analysis
For immunocytochemistry, cultures were fixed at DIV14-16 with 4% paraformaldehyde/0.1M phosphate buffer for 20 min and then washed with PBS. Immunostains of CgA were performed following methanol fixation (15 min methanol at -20 °C). Coverslips were blocked and permeabilized in Buffer D (2% donkey serum, 0.1% Triton X-100, and 0.05% sodium azide in 2X PBS) for 20 min., and then incubated with primary antibody in Buffer D at 4 °C overnight. Coverslips were then washed 3 times for 3 min each in PBS. Coverslips were incubated with secondary antibody in buffer D at room temp for 2 h and washed again 3 times for 3 min each in PBS. Coverslips were mounted with Fluoromount Plus (Diagnostic Biosystems) sealed with nail polish and examined with a 40X 1.3 NA oil Zeiss Plan-Apochromat DIC objective on a Zeiss LSM 710 confocal microscope. For co-localization analysis, we used ImageJ and Metamorph software. Percent colocalization was determined from the percentage of the total thresholded area of one channel that overlapped with the thresholded area of the other channel for two different secondary fluorophores, using Metamorph software.
HEK cell culture and transfection HEK cells were cultured in DMEM medium with 10% FBS and 1% penicillin/streptomycin in 10 cm culture dishes at 37 °C in a 5% CO 2 humidified incubator. Cultures at 40-50% confluence were transfected using calcium phosphate: 20 µg plasmid DNA was added to 166 µl 2 M CaCl 2 in a total volume of 1.3 ml dH 2 0 and gently mixed using a pipette. 1.3 ml transfection buffer (274 mM NaCl, 10 mM KCl, 1.4 mM Na 2 HPO 4 , 15 mM glucose, 42 mM Hepes, pH 7.09) was added dropwise under gentle vortex. This mixture was then added dropwise per 10 cm plate, and cultures incubated overnight at 37 °C in a 5% CO 2 humidified incubator. The following day, the media was removed, cultures were washed twice with pre-warmed PBS and fresh media was added.
In silico kinase prediction GPS 3.0 software (Zhou et al., 2004 ) was used as a tool to predict kinases capable of phosphorylating Syt4 at S135 and c-Jun (as a control) at S63. Peptides for WT Syt4: PETEKEAVSPESLKSST, and WT c-Jun: AKNSDLLTSPDVGLLKL, were submitted to the prediction software with a medium threshold (corresponding to a false positive rate (FPR) equal to 6). All available serine/threonine kinases were selected as potential kinases. The software reported a score and a cutoff for each kinase. All kinases with Score/Cutoff > 2 were classified as significant predicted kinases for phosphorylation of S135 in Syt4 and S63 in cJun.
In vitro kinase assay
Peptides for WT Syt4; PETEKEAVSPESLKSST, phosphodeficient Syt4 (S135A); PETEKEAVAPESLKSST, WT c-Jun; AKNSDLLTSPDVGLLKL, and phosphodeficient c-Jun (S63A); AKNSDLLTAPDVGLLK were synthesized by GenScript Biotech Corporation (Piscataway, NJ, USA). The ADP-GloTM Kinase assay kit (Promega) was used with JNK1 (R&D Systems) according to the manufacturer's instructions. In all assays 0.2 µg/µl of each peptide and 5 µM ATP were used. Standard curves were obtained by measuring the luminescence of a series of ADP-ATP dilutions according to the kit protocol. Phosphorylation of WT Syt4 and c-Jun peptides by JNK1 was calculated based on standard curves and reported as % activity (which includes potential autophosphorylation). JNK activity of phosphodeficient Syt4 or c-Jun mutants was normalized to control for comparison.
Western blots
12-14 DIV neurons in 10 cm dishes were washed in PBS. Cells were harvested in PBS and passed through a 27-gauge needle. Lysates were centrifuged at 4000 rpm for 10 min to pellet nuclei and cellular debris. Protein concentration of supernatants was determined by BCA assay (Novagen, cat. no. 712853) according to the manufacturer's instructions. Equal amounts of protein were then loaded per lane for comparison between conditions, resolved by SDS-PAGE, and analyzed by immunoblotting.
Co-Immunoprecipitation
For co-immunoprecipitation experiments, transfected confluent HEK293 cells growing in 10 cm dishes were harvested in IP-Lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.5% NP40, Complete protease inhibitor (Roche)). Cell lysates were then incubated with 30 μl of antibody coupled Protein A/G Dynabeads (Invitrogen) or GFP-Trap beads (Chromotech) for 2 h at 4 °C on a rotator. Uncoupled beads were used for binding controls. Supernatant was saved as the unbound fraction and bound proteins from beads were eluted by incubating beads for 10 min at 95 °C in 4X SDS sample buffer. Samples were then analyzed by SDS-PAGE and western blotting.
